Nephron commits to over $400M in 10-year syringe purchases from Sharps Technology

Nephron Pharmaceuticals committed to minimum orders of over $400 million over 10 years from Sharps Technology, starting with about $30 million of revenue in the first year, with product delivery scheduled for Q1 2024.

“Nephron commits to minimum orders of over $400 Million over 10 years; $30 Million in revenue the first year”globenewswire.com

• 1 source
• globenewswire.comSharps Technology Signs Asset Purchase Agreement to AcquireSep 26, 2023

Summarized from public sources; check the original articles before acting on it.